Received Mar 11, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | 1 | LL347 | — |
wrong administration of a MENVEO 1 vial shot to a 13-month-old patient; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 13-month-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number LL347, expiry date 31-JAN-2027) for prophylaxis. On 03-MAR-2026, the patient received the 1st dose of Menveo. On 03-MAR-2026, an unknown time after receiving Menveo, the patient experienced inappropriate age at vaccine administration (Verbatim: wrong administration of a MENVEO 1 vial shot to a 13-month-old patient). The outcome of the inappropriate age at vaccine administration was not applicable. Additional Information: GSK Receipt Date: 03-MAR-2026 On 03-MAR-2026, a Medical Assistant called to get guidance with the wrong administration of a Menveo 1 vial shot to a 13-month-old patient. She wanted to know how to proceed and if there were some risks or safety concerned for the patient. She mentioned the patient was not supposed to receive any meningococcal vaccine and that this vaccine was for 10 year and older patients and that was why she called. The batch number was not provided and a request for this information has been made.